The cell line has been screened to confirm the absence of Mycoplasma species.
Background
RPMI 8226 cells are human B cells isolated from a plasmacytoma/myeloma patient. RPMI 8226 cells constitutively express BCMA and offer a physiologically relevant platform to evaluate cancer-directed immunotherapies, such as Chimeric Antigen Receptor (CAR) T cells. The Firefly Luciferase RPMI 8226 Cell Line makes an excellent target to measure specific killing by CAR-T or NK cells targeting BCMA or other targets of interest.
Storage/Stability
Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage.
Growth Media
For best results, it is highly recommended to use these validated and optimized media from BPS Bioscience. Other preparations or formulations of media may result in suboptimal performance.
Thaw Medium 10 (BPS Bioscience, #79704): RPMI 1640 medium supplemented with 10% FBS, 1 mM Sodium pyruvate, 1% Non-essential amino acids, 1% Penicillin/streptomycin.
Growth Medium 10A (BPS Bioscience, #79835): RPMI 1640 medium supplemented with 10% FBS, 1 mM Sodium pyruvate, 1% Non-essential amino acids, 1% Penicillin/streptomycin with 400 μg/ml of Geneticin to ensure recombinant expression.
Applications
Use as a target cell in co-culture cytotoxicity assays.
Perform bioluminescence imaging of tumor growth in vivo.
Assess the effect of therapeutic compounds on cell proliferation in vivo and in vitro.
Shipping Temperature
-80°C
Notes
License Disclosure Visit bpsbioscience.com/license for the label license and other key information about this product.